Revised diagnostic criteria for neurocysticercosis

被引:213
|
作者
Del Brutto, O. H. [1 ]
Nash, T. E. [2 ]
White, A. C., Jr. [3 ]
Rajshekhar, V. [4 ]
Wilkins, P. P. [5 ]
Singh, G. [6 ]
Vasquez, C. M. [7 ]
Salgado, P. [8 ]
Gilman, R. H. [9 ]
Garcia, H. H. [10 ,11 ,12 ]
机构
[1] Univ Espiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador
[2] NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA
[4] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India
[5] Parasitol Serv, Marathon, FL USA
[6] Dayanand Med Coll, Dept Neurol, Ludhiana, Punjab, India
[7] Inst Natl Ciencias Neurol, Dept Neurosurg, Lima, Peru
[8] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Neuroimaging Unit, Mexico City, DF, Mexico
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[10] Ctr Global Hlth, Tumbes, Peru
[11] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru
[12] Inst Natl Ciencias Neurol, Cysticercosis Unit, Jr Ancash 1271, Lima 1, Peru
基金
英国惠康基金;
关键词
Cysticercosis; Neurocysticercosis; Taenia solium; Diagnostic criteria; epilepsy; intracranial hypertension; BRUNS-SYNDROME; VENTRICULAR NEUROCYSTICERCOSIS; INTRACRANIAL CALCIFICATIONS; HUMAN CYSTICERCOSIS; COLLOID CYST; ASSAY; ALBENDAZOLE; MIMICKING; ENDOSCOPY; EPILEPSY;
D O I
10.1016/j.jns.2016.11.045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A unified set of criteria for neurocysticercosis (NCC) has helped to standardize its diagnosis in different settings. Methods: Cysticercosis experts were convened to update current diagnostic criteria for NCC according to two principles: neuroimaging studies are essential for diagnosis, and all other information provides indirect evidence favoring the diagnosis. Recent diagnostic advances were incorporated to this revised set. Results: This revised set is structured in absolute, neuroimaging and clinical/exposure criteria. Absolute criteria include: histological confirmation of parasites, evidence of subretinal cysts, and demonstration of the scolex within a cyst. Neuroimaging criteria are categorized as major (cystic lesions without scolex, enhancing lesions, multilobulated cysts, and calcifications), confirmative (resolution of cysts after cysticidal drug therapy, spontaneous resolution of single enhancing lesions, and migrating ventricular cysts on sequential neuroimaging studies) and minor (hydrocephalus and leptomeningeal enhancement). Clinical/exposure criteria include: detection of anticysticercal antibodies or cysticercal antigens by well-standardized tests, systemic cysticercosis, evidence of a household Taenia carrier, suggestive clinical manifestations, and residency in endemic areas. Besides patients having absolute criteria, definitive diagnosis can be made in those having two major neuroimaging criteria (or one major plus one confirmative criteria) plus exposure. For patients presenting with one major and one minor neuroimaging criteria plus exposure, definitive diagnosis of NCC requires the exclusion of confounding pathologies. Probable diagnosis is reserved for individuals presenting with one neuroimaging criteria plus strong evidence of exposure. Conclusions: This revised set of diagnostic criteria provides simpler definitions and may facilitate its more uniform and widespread applicability in different scenarios. (C) 2016 The Authors. Published by Elsevier B.V.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [21] Current challenges in neurocysticercosis: recent data and where we are heading
    Coyle, Christina M.
    Bustos, Javier A.
    Garcia, Hector H.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (05) : 313 - 319
  • [22] Update on the Diagnosis and Management of Neurocysticercosis
    Webb, Camille M.
    White, A. Clinton, Jr.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (12)
  • [23] Neurocysticercosis
    Takayanagui, Osvaldo M.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (9B) : 710 - 713
  • [24] Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world
    Bustos, J.
    Gonzales, I
    Saavedra, H.
    Handali, S.
    Garcia, H. H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 427
  • [25] Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?
    Garcia, Hector H.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (03) : 295 - 298
  • [26] Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis
    Sotelo, Julio
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (06) : 529 - 535
  • [27] Microsurgical Treatment of Epilepsy with Parenchymal Neurocysticercosis
    Tan, Yu-tang
    Zhang, Suo-jun
    Shu, Kai
    Lei, Ting
    Niu, Hong-quan
    CURRENT MEDICAL SCIENCE, 2019, 39 (06) : 984 - 989
  • [28] Racemose Neurocysticercosis
    Das, Rohit R.
    Tekulve, Kristyn J.
    Agarwal, Atul
    Tormoehlen, Laura M.
    SEMINARS IN NEUROLOGY, 2012, 32 (05) : 550 - 555
  • [29] Neurocysticercosis: is serology useful in the absence of brain imaging?
    Garcia, Hector H.
    Rodriguez, Silvia
    Gilman, Robert H.
    Gonzalez, Armando E.
    Tsang, Victor C. W.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (08) : 1014 - 1018
  • [30] Clinical and radiological diagnosis of neurocysticercosis: A case report
    Navarro, D.
    Huarte, I.
    Santesteban, R.
    Bidarte, M.
    Ayechuz, A.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2009, 32 (02) : 269 - 273